Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/174304
Title: | New fluorogenic probes for neutral and alkaline ceramidases |
Author: | Casasampere Ferrer, Mireia Bielsa, Núria Riba, Daniel Bassas, Laura Xu, Ruijuan Mao, Cungui Fabriàs Domingo, Gemma Abad Saiz, José Luis Delgado Cirilo, Antonio Casas Brugulat, Josefina |
Keywords: | Esfingolípids Síntesi orgànica Sphingolipids Organic synthesis |
Issue Date: | 27-Mar-2019 |
Publisher: | American Society for Biochemistry and Molecular Biology |
Abstract: | New fluorogenic ceramidase substrates derived from the N-acyl modification of our previously reported probes (RBM14) are reported. While none of the new probes were superior to the known RBM14C12 as acid ceramidase substrates, the corresponding nervonic acid amide (RBM14C24:1) is an efficient and selective substrate for the recombinant human neutral ceramidase, both in cell lysates and in intact cells. A second generation of substrates, incorporating the natural 2-(N-acylamino)-1,3-diol-4-ene framework (compounds RBM15) is also reported. Among them, the corresponding fatty acyl amides with an unsaturated N-acyl chain can be used as substrates to determine alkaline ceramidase (ACER)1 and ACER2 activities. In particular, compound RBM15C18:1 has emerged as the best fluorogenic probe reported so far to measure ACER1 and ACER2 activities in a 96-well plate format. Keywords: ceramides; sphingolipids; substrate; umbelliferone. |
Note: | Reproducció del document publicat a: https://doi.org/10.1194/jlr.D092759 |
It is part of: | Journal of Lipid Research, 2019, vol. 60, num. 6, p. 1174-1181 |
URI: | https://hdl.handle.net/2445/174304 |
Related resource: | https://doi.org/10.1194/jlr.D092759 |
ISSN: | 0022-2275 |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
691690.pdf | 1.03 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.